首页 | 本学科首页   官方微博 | 高级检索  
     

齐拉西酮与氟哌啶醇治疗精神分裂症的对照研究
引用本文:李予春,杨鸽,程德君. 齐拉西酮与氟哌啶醇治疗精神分裂症的对照研究[J]. 中国现代医药杂志, 2011, 13(3): 22-24
作者姓名:李予春  杨鸽  程德君
作者单位:新乡医学院第二附属医院普通精神科,453002
摘    要:目的探讨齐拉西酮与氟哌啶醇治疗精神分裂症的疗效和安全性。方法将94例符合CCMD-3诊断标准的精神分裂症患者随机分为两组,分别给予齐拉西酮和氟哌啶醇治疗8周。分别于治疗前和治疗后2、4、6、8周末采用阳性症状和阴性症状量表(PANSS)评定临床疗效,副反应量表(TESS)评定副反应。结果治疗8周后,两组疗效近似(P>0.05),齐拉西酮组和氟哌啶醇组的有效率无显著性差异;齐拉西酮组的副反应发生率低于氟哌啶醇组,但无显著性差异。氟哌啶醇组锥体外系副反应明显高于齐拉西酮组(P<0.05)。结论齐拉西酮与氟哌啶醇对精神分裂症患者的疗效相当,副作用较小。

关 键 词:齐拉西酮  氟哌啶醇  精神分裂症  疗效

Contrast study of Ziprasidone and Haloperidol in the treatment of patients with Schizophrenia
Li Yuchun,Yang Ge,Cheng Dejun. Contrast study of Ziprasidone and Haloperidol in the treatment of patients with Schizophrenia[J]. Modern Medicine Journal of China, 2011, 13(3): 22-24
Authors:Li Yuchun  Yang Ge  Cheng Dejun
Affiliation:Li Yuchun,Yang Ge,Cheng Dejun.The Second Affiliated Hospital of Xinxiang Medical College,Xinxiang 453002
Abstract:Objective To study the efficacy and safety of Ziprasidone and Haloperidol in the treatment of Schizophrenia patients.Methods 94 patients with Schizophrenia by CCMD-3 were randomly allocated to two groups,treated respectively with Ziprasidone or Haloperidol for 8 weeks.The PANSS and TESS were employed to evaluate the efficacy and adverse effects respectively before and at the ends of 2,4,6,and 8 weeks treatment.Results The total effective rates for the Ziprasidone and Haloperidol groups were similar after th...
Keywords:Ziprasidone Haloperidol Schizophrenia Efficacy  
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号